Robert N. Wilson, Director at SYNTA PHARMACEUTICALS CORP (SNTA), bought 155,830 shares at $10.00 ($1.0M) on 2007-02-09, disclosed to the SEC on 2007-02-13.
Open-market purchase of $1.0M SNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,857 | $0 | 0.0% |
| 2 | $0.00 | 52,973 | $0 | 0.0% |
| 3 | $10.00 | 100,000 | $1.0M | 100.0% |
| Total | $6.42 avg | 155,830 | $1.0M | 100% |
| Filing → |
| CALC | BUY | 2024-08-26 | $201K | — | Filing → |
| CALC | BUY | 2024-07-02 | $361K | — | Filing → |
| CALC | BUY | 2024-07-01 | $27K | — | Filing → |